The evidence behind cinnamon for metabolic health. Which cinnamon matters, dose ranges, coumarin safety, and how cinnamon fits into GlycoCare.
By Dr. Nathan Riley, MD · Published April 12, 2026 · Updated April 24, 2026
Cinnamon is one of the most familiar spices in the kitchen cupboard and one of the most studied botanicals in metabolic health research. Its reputation for supporting healthy blood sugar has produced decades of clinical trials, meta-analyses, and consumer supplement products. The picture that emerges from the published evidence is more nuanced than either enthusiastic marketing or blanket dismissal suggests.
This article examines what cinnamon actually does to blood sugar according to peer-reviewed research, which type of cinnamon matters, the dosing range that has produced effects in trials, who should exercise caution, and how cinnamon fits into the broader GlycoCare formulation.
The word "cinnamon" in English covers several different botanical species, and the distinction matters more than most consumers realise. Two varieties dominate commerce:
Cinnamomum verum (Ceylon cinnamon, also called "true cinnamon") is native to Sri Lanka and has a delicate, sweet flavour. It contains minimal coumarin — a compound that at high intake can stress the liver.
Cinnamomum cassia (Chinese cinnamon) is what most people eat and what appears in most supermarket cinnamon, Cinnamon Toast Crunch, and the majority of commercial supplements. It is stronger in flavour and considerably higher in coumarin. Importantly, most of the clinical research on cinnamon and blood sugar has been conducted using cassia rather than verum.
GlycoCare lists Cinnamon Bark as one of its twelve ingredients but does not currently specify which species. For a supplement intended for daily long-term use, this would be worth clarifying on the product label.
Cinnamon's effects on glucose metabolism are attributed primarily to a class of polyphenols called A-type procyanidins, and particularly to a compound known as methylhydroxychalcone polymer, or MHCP. Laboratory research suggests MHCP may mimic some of the cellular actions of insulin, particularly at the level of the insulin receptor and downstream glucose transporters.
In practical terms, this translates into potential effects on:
The consistency of these findings across trials is mixed. Some trials show clear effects; others show none. Meta-analyses generally conclude that cinnamon produces a statistically detectable but clinically modest improvement in glycaemic markers. The National Center for Complementary and Integrative Health maintains an ongoing summary of the evidence.
Clinical trials have used cinnamon doses ranging from 120 mg to 6 grams daily, with most positive trials clustered in the 1 to 3 gram range. Extract-based products use lower doses because the extraction process concentrates the active compounds. Doses above 6 grams per day have not demonstrated greater efficacy and raise safety concerns with cassia cinnamon specifically because of coumarin load.
The European Food Safety Authority has set a tolerable daily intake for coumarin at 0.1 mg per kilogram of body weight. For a 70 kg adult, that is 7 mg of coumarin daily. Cassia cinnamon contains roughly 2 to 10 mg of coumarin per gram, which means that 3 to 6 grams of cassia daily can exceed this threshold. The threshold is not a hard safety limit but a cautionary level. For anyone taking cinnamon long-term, Ceylon cinnamon (with negligible coumarin) is the safer choice.
You can explore the underlying clinical evidence on PubMed by searching for "cinnamon blood glucose insulin."
Cinnamon is generally well tolerated, but meaningful cautions apply:
Liver conditions: Anyone with diagnosed liver disease, elevated liver enzymes, or heavy alcohol use should avoid high-dose cassia cinnamon due to coumarin's hepatotoxic potential. Ceylon cinnamon is a safer option.
Anticoagulants: Cassia cinnamon contains compounds with mild anticoagulant activity. Concurrent use with warfarin, apixaban, rivaroxaban, or aspirin warrants medical supervision.
Diabetes medication: Like other blood sugar-lowering ingredients, concurrent use with insulin or sulfonylureas can additively lower glucose. Blood glucose monitoring and possible medication adjustment may be needed.
Surgery: Because of the mild anticoagulant activity, cinnamon supplementation should be discontinued at least two weeks before any planned surgical procedure.
In the GlycoCare formulation, Cinnamon Bark sits alongside Banaba Leaf, Gymnema Sylvestre, Bitter Melon, and White Mulberry Leaf in what can be thought of as the botanical glucose support layer. The rationale for combining them is that each botanical targets slightly different aspects of glucose metabolism, and cumulative effects may be more reliable than single-ingredient effects.
The practical result is that GlycoCare provides a smaller dose of cinnamon than a single-ingredient cinnamon supplement would, but balances this with the other four botanicals. For daily long-term maintenance in healthy adults, this is a reasonable trade-off. For someone seeking the highest possible clinical-trial-equivalent dose of cinnamon specifically, a higher-potency single-ingredient product taken under medical supervision would be a more targeted choice.
Cinnamon is a legitimate, well-researched botanical with modest but real effects on glucose metabolism. The most convincing evidence applies to A-type procyanidins and MHCP from cassia cinnamon at doses of 1 to 3 grams daily. Extract-based products deliver active compounds at lower milligram totals. Ceylon cinnamon is safer than cassia for long-term supplementation. GlycoCare includes cinnamon as one component of a multi-pathway formula and is most appropriate for healthy adults seeking daily maintenance rather than clinical-level glucose intervention.
This article is for educational purposes only and is not medical advice. Always consult your physician before starting any supplement, particularly if you have diabetes, prediabetes, hypoglycemia, or take any prescription medication for blood sugar control. Individual response varies. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA.